ofatumumab,rituximab,blinatumomab
novartis,amgen,astellas
['blina ', 'blinatumomab', 'ofatumumab', 'ritux', 'leusm']
congress | #ash22 | poster , shared the updated phase ii results of ino added to hyper-cvad + blinatumomab in pts with nd ph-negative b-all, which proved highly effective and safe, with an estimated 1-year os of 100% #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm